SCHEMBL5695482

SCHEMBL5695482

O=C(O)N1CCN(C(=O)C(c2cccc(Br)c2)C2(O)CCCCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TP53 P04637 1/20 0.39
LMNA P02545 4/20 0.38
KMT2A Q03164 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.37
CHRM3 P20309 3/20 0.36
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM4 P08173 1/20 0.36
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
SLC6A2 P23975 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27655996 0.96 ALDH1A1 (0.40) ALDH1A1TP53LMNAKMT2ANPSR1
SCHEMBL27655973 0.88 CHRM1 (0.40) ALDH1A1TP53LMNANPSR1CHRM3
SCHEMBL27681882 0.88 ALDH1A1 (0.41) ALDH1A1TP53LMNAKMT2ANPSR1
SCHEMBL3956862 0.87 ALDH1A1 (0.41) ALDH1A1KMT2APOLBHPGDSMN1; SMN2
SCHEMBL3954346 0.86 SLC6A2 (0.47) LMNANPSR1SLC6A2SLC6A3
SCHEMBL27661852 0.86 SLC6A2 (0.47) LMNANPSR1SLC6A2SLC6A3
SCHEMBL27661848 0.86 SLC6A2 (0.47) ALDH1A1TP53LMNAKMT2ANPSR1
SCHEMBL27681433 0.86 SLC6A2 (0.47) LMNANPSR1SLC6A2SLC6A3
SCHEMBL27655992 0.85 LMNA (0.39) ALDH1A1LMNAKMT2ANPSR1MEN1
SCHEMBL4260651 0.84 MEN1 (0.40) ALDH1A1LMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 CN disclosed
CN-1894226-A Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use WYETH CORP (US) 2007-01-10 CN disclosed
CN-1894227-A Phenylpiperazine cycloalkanol derivatives and methods of their use WYETH CORP (US) 2007-01-10 CN disclosed
EP-1673358-A1 PHENYLPIPERAZINE CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE Wyeth (US) 2006-06-28 EP disclosed
WO-2005037808-A1 PHENYLPIPERAZINE CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2005-04-28 WO disclosed